To assess the benefits of transplantation on the quality of life (QOL) for transplant patients.
Data extraction
The authors do not state who, or how many of the reviewers, extracted the data.
The authors classified the results of each study's assessment of a given QOL domain in terms of whether the study found 1) QOL benefits in the domain, versus 2) mixed evidence, versus 3) no evidence of benefits in the domain. These assessments were then used in the analyses.
Methods of synthesis
How were the studies combined? For each of the four QOL domains, the proportion of studies providing evidence of QOL benefits of transplantation was determined. These proportions were calculated separately for each domain of QOL, and, within these four domains, separately for each of the six areas of transplantation. The authors then calculated:
1. The average effect size, or average proportion of studies finding benefits in a given QOL domain across the six areas of transplantation.
2. Whether this average effect was greater than zero.
3. Whether the majority of studies found evidence of benefit.
4. Whether the effect sizes differed across the six areas of transplantation.
How were differences between studies investigated?
The authors have tested for homogeneity using the chi-square test.
Results of the review
Two hundred and eighteen (218) studies were included in the review with approximately 14,750 participants. Of the 218 studies, 30.3% were of kidney, 22.5% were of heart, 18.3% were of liver, 15.6% were of bone marrow, 8.7% were of pancreas/kidney-pancreas, and 4.6% were of lung/lung-heart transplantations. Of the 14,750 participants, 45.6% were kidney, 19.2% were heart, 16.4% were liver, 13.0% were bone marrow, 3.1% were of pancreas/kidney-pancreas, and 2.7% were of lung/lung-heart transplant patients.
In the first question: does QOL improve from pre-to post-transplant?, the majority of 76 prospective studies reported statistically significant (p < 0.05) pre-to post-transplant improvements in physical functional QOL, mental health/cognitive status, social functioning, and overall QOL perceptions. The mean proportion of studies reporting QOL improvement in the physical, mental, social and overall domains were 86%, 61.8%, 67.4% and 100% respectively. There was no statistically significant heterogeneity across transplant areas.
In the second question: is QOL in transplant recipients better than QOL in similarly ill comparison samples?, the majority of 84 studies reported physical functional and global QOL advantages for transplant recipients relative to similarly-ill comparison groups. The mean proportion of studies reporting QOL improvement in the physical, mental, social and overall domains were 57.7%, 36.2%, 44.6% and 58.7% respectively. There was no statistically significant heterogeneity across transplant areas. In the third question: is QOL in transplant recipients similar to or better than QOL in healthy samples?, the analysis of 67 studies did not indicate that recipient QOL in specific functional areas equalled that of healthy, non-patient cohorts. The mean proportion of studies reporting QOL improvement in the physical, mental, social and overall domains were 20.8%, 49.6%, 39.1% and 47.0% respectively. Statistically significant heterogeneity was found for overall QOL studies, but in the remaining three domains there was no statistically significant heterogeneity across transplant areas.
